论文部分内容阅读
目的:观察联合雾化吸入治疗老年喘息型慢性支气管炎的临床疗效。方法:选择我院2015年8月-2017年3月收治的老年喘息型慢性支气管炎患者148例,随机分为对照组和观察组,每组74例,在常规内科治疗的基础上,对照组加用盐酸氨溴索氧化雾化吸入,观察组加用异丙托溴铵溶液、硫酸特布他林联合布地奈德混悬液联合雾化吸入治疗。比较两组的临床疗效、临床症状积分以及住院时间。结果:观察组的临床总有效率明显高于对照组(93.24%VS 81.08%),差异有统计学意义(P<0.05);与对照组比较,观察组咳嗽咳痰、胸闷、喘憋等临床症状积分以及住院时间均显著降低,差异均有统计学意义(P<0.05)。结论:联合雾化吸入可以显著的改善老年喘息型慢性支气管炎的临床症状,取得显著的临床疗效,缩短住院时间,值得进行推广应用。
Objective: To observe the clinical efficacy of combined inhalation therapy in the treatment of asthmatic chronic bronchitis in the elderly. Methods: A total of 148 elderly patients with wheezing chronic bronchitis who were admitted to our hospital from August 2015 to March 2017 were randomly divided into control group and observation group, with 74 cases in each group. On the basis of routine medical treatment, Plus ambroxol hydrochloride atomized inhalation, the observation group plus ipratropium bromide solution, terbutaline sulfate and budesonide suspension combined with inhalation therapy. The clinical efficacy, clinical symptom scores and hospital stay were compared between the two groups. Results: The total clinical effective rate in the observation group was significantly higher than that in the control group (93.24% vs 81.08%, P <0.05). Compared with the control group, the cough and phlegm, chest tightness, wheezing and so on Symptoms and hospital stay were significantly reduced, the differences were statistically significant (P <0.05). Conclusion: Combined inhalation can significantly improve the clinical symptoms of asthmatic patients with chronic bronchitis, achieved significant clinical efficacy, shorten the hospital stay, it is worth to promote the use of.